Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response.

Lee U, Szabova L, Collins VJ, Gordon M, Johnson K, Householder D, Jorgensen S, Lu L, Bassel L, Elloumi F, Peer CJ, Nelson AE, Varriano S, Varma S, Roberts RD, Ohler ZW, Figg WD, Sharan SK, Pommier Y, Heske CM

Open source

DOI: 10.3389/fcell.2024.1462840
Published: 2024
Container: Frontiers in cell and developmental biology
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3389/fcell.2024.1462840,
  title = {Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response.},
  author = {Lee U and Szabova L and Collins VJ and Gordon M and Johnson K and Householder D and Jorgensen S and Lu L and Bassel L and Elloumi F and Peer CJ and Nelson AE and Varriano S and Varma S and Roberts RD and Ohler ZW and Figg WD and Sharan SK and Pommier Y and Heske CM},
  year = {2024},
  journal = {Frontiers in cell and developmental biology},
  doi = {10.3389/fcell.2024.1462840},
  url = {https://doi.org/10.3389/fcell.2024.1462840}
}

RIS

TY  - JOUR
TI  - Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response.
AU  - Lee U
AU  - Szabova L
AU  - Collins VJ
AU  - Gordon M
AU  - Johnson K
AU  - Householder D
AU  - Jorgensen S
AU  - Lu L
AU  - Bassel L
AU  - Elloumi F
AU  - Peer CJ
AU  - Nelson AE
AU  - Varriano S
AU  - Varma S
AU  - Roberts RD
AU  - Ohler ZW
AU  - Figg WD
AU  - Sharan SK
AU  - Pommier Y
AU  - Heske CM
PY  - 2024
JO  - Frontiers in cell and developmental biology
DO  - 10.3389/fcell.2024.1462840
UR  - https://doi.org/10.3389/fcell.2024.1462840
ER  -

APA

U, L., L, S., VJ, C., M, G., K, J., D, H., S, J., L, L., L, B., F, E., CJ, P., AE, N., S, V., S, V., RD, R., ZW, O., WD, F., SK, S., Y, P., & CM, H. (2024). Treatment with novel topoisomerase inhibitors in Ewing sarcoma models reveals heterogeneity of tumor response.. Frontiers in cell and developmental biology. https://doi.org/10.3389/fcell.2024.1462840

Source records

pubmed · retrieved 2026-11-10T08:26:38.671Z